Provides a training structure for introducing treatment program staff to the evidence-based practices for co-occurring disorders presented in Treatment Improvement Protocol 42. It focuses on what the substance abuse treatment clinician needs to know to address co-occurring disorders in treatment programs.

This TIP provides information about the field of co-occurring substance use and mental disorders, and captures the state of the art in the treatment of people with co-occurring disorders.

Opioid addiction is a problem with high costs to individuals, families, and society. This TIP provides a detailed description of medication-assisted treatment for opioid addiction, including optional approaches such as comprehensive maintenance treatment, detoxification, and medically supervised withdrawal.

Research consistently demonstrates a strong connection between criminal activity and substance abuse; research also finds that involvement in substance abuse treatment reduces recidivism for offenders who use drugs.

This TIP is a revision of TIP 19, Detoxification From Alcohol and Other Drugs. TIP 45 was developed by a panel of experts and it provides up-to-date information about the role of detoxification in the continuum of services for individuals with substance use disorders.

Provides a training program for substance abuse treatment staff on detoxification and withdrawal. Discusses detox services for specific substances, psychosocial and biomedical issues, co-occurring medical and psychiatric conditions, and financing issues.

This TIP was written to help administrators address the changing environment in which outpatient treatment programs operate.

This TIP addresses the practical needs of treatment providers as they design and implement IOT programs.

This TIP provides substance abuse counselors the "what," "why," and "how-to" of working with clients with depressive symptoms and substance use disorders.

This TIP provides clinical guidelines for the proper use of medications in the treatment of alcohol use disorders. The underlying objective is to expand access to information about the effective use of these medications, not only in specialty substance abuse treatment programs but through physicians offices and other general medical care settings.